Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu

Am J Psychiatry. 2024 Oct 1;181(10):936-937. doi: 10.1176/appi.ajp.20240111r.

Authors

Roger S McIntyre¹, Angela T H Kwan¹, Joshua D Rosenblat¹, Kayla M Teopiz¹, Rodrigo B Mansur¹

Affiliation

¹ Department of Psychiatry, University of Toronto, Toronto (McIntyre, Rosenblat, Mansur); Department of Pharmacology, University of Toronto, Toronto (McIntyre); Brain and Cognition Discovery Foundation, Toronto (McIntyre, Kwan, Teopiz); Faculty of Medicine, University of Ottawa, Ottawa, Ont. (Kwan).

PMID: 39350620
DOI: 10.1176/appi.ajp.20240111r

No abstract available

Keywords: Adverse Effects of Medication; Metabolism.

Publication types

Letter

MeSH terms

Antipsychotic Agents* / adverse effects
Antipsychotic Agents* / therapeutic use
Aripiprazole* / adverse effects
Aripiprazole* / therapeutic use
Clozapine* / adverse effects
Clozapine* / therapeutic use
Drug Therapy, Combination
Humans
Piperazines / adverse effects
Piperazines / therapeutic use
Quinolones / adverse effects
Quinolones / therapeutic use
Schizophrenia / drug therapy
Weight Gain* / drug effects

Substances

Clozapine
Aripiprazole
Antipsychotic Agents
Quinolones
Piperazines